WELLS FARGO & COMPANY/MN - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,297,976
-38.1%
28,223
-22.7%
0.00%
-100.0%
Q2 2023$2,097,195
+227.2%
36,492
+113.5%
0.00%
Q1 2023$640,914
+550.9%
17,091
+386.4%
0.00%
Q4 2022$98,462
-28.1%
3,514
-27.7%
0.00%
Q3 2022$137,000
-79.2%
4,861
-74.3%
0.00%
Q2 2022$659,000
-77.2%
18,932
-76.5%
0.00%
-100.0%
Q1 2022$2,896,000
+71.9%
80,685
+11.5%
0.00%
Q4 2021$1,685,000
-71.9%
72,337
-77.1%
0.00%
-100.0%
Q3 2021$6,001,000
-19.1%
315,629
-14.2%
0.00%
-50.0%
Q2 2021$7,419,000
+122.1%
368,019
+101.8%
0.00%
+100.0%
Q1 2021$3,341,000
-7.6%
182,335
+1.4%
0.00%0.0%
Q4 2020$3,615,000
-7.8%
179,736
-14.0%
0.00%0.0%
Q3 2020$3,920,000
-25.3%
209,040
-10.6%
0.00%
-50.0%
Q2 2020$5,249,000
+253.5%
233,710
+133.5%
0.00%
+100.0%
Q1 2020$1,485,000
-59.2%
100,092
-47.0%
0.00%0.0%
Q4 2019$3,640,000
+4.6%
188,728
+7.5%
0.00%0.0%
Q3 2019$3,481,000
-20.0%
175,545
-14.8%
0.00%0.0%
Q2 2019$4,351,000
-16.7%
206,110
-19.4%
0.00%
-50.0%
Q1 2019$5,226,000
-2.5%
255,844
-5.0%
0.00%0.0%
Q4 2018$5,359,000
+15.5%
269,328
+11.7%
0.00%
+100.0%
Q3 2018$4,638,000
+54.0%
241,037
+22.2%
0.00%0.0%
Q2 2018$3,011,000
-16.5%
197,310
+2.6%
0.00%0.0%
Q1 2018$3,606,000
+6.3%
192,369
+9.1%
0.00%0.0%
Q4 2017$3,392,000
+175.5%
176,323
+156.1%
0.00%
Q3 2017$1,231,000
+1.5%
68,837
+1.3%
0.00%
Q2 2017$1,213,000
+1.3%
67,969
-17.8%
0.00%
Q1 2017$1,198,000
-24.1%
82,665
-3.5%
0.00%
-100.0%
Q4 2016$1,579,000
+56.3%
85,680
+61.0%
0.00%
Q3 2016$1,010,000
+124.9%
53,213
+91.0%
0.00%
Q2 2016$449,000
+109.8%
27,864
+56.4%
0.00%
Q1 2016$214,000
+18.2%
17,820
+40.3%
0.00%
Q4 2015$181,000
+105.7%
12,704
+69.3%
0.00%
Q3 2015$88,000
-29.6%
7,502
+5.8%
0.00%
Q2 2015$125,000
-67.9%
7,089
-72.7%
0.00%
Q1 2015$390,000
+7700.0%
26,008
+5976.6%
0.00%
Q4 2014$5,0004280.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders